Pasithea Therapeutics Corp. Warrants (KTTAW)
NCM · Warrant · CUSIP 70261F111
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for KTTAW and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
70261F111
Parent Company
Pasithea Therapeutics Corp (KTTA)
Business: Pasithea Therapeutics Corp. is a biopharmaceutical company dedicated to developing new therapies for the treatment of central nervous system (CNS) diseases. The flagship company program is focused on discovering new and effective treatments for mental health problems.

Company Contact

CEO
Tiago Reis Marques
CFO
Dan Schneiderman
Headquarters
1111 Lincoln Road, Suite 500, Miami Beach, FL 33139
Phone
702-514-4174
Investor Relations
info@pasithea.com
SEC EDGAR Filings
View filings »